Shortened TB Treatment Guidelines Released By CDC

Recommend to others!

Improvements in the various treatment options for many diseases have made significant impact on the life of many individuals who are suffering from these diseases. However, there are certain diseases which necessitates a prolonged period of time as far as treatment regimen is concerned. One of which is the Tuberculosis (TB).

Up to this date, the shortest period of time wherein an individual who is harboring the tuberculosis causing microorganism can be considered TB free is about nine months, and this nine months is already considered long enough which adds burden to the family taking into account financial constraints and the period of time which the individual needs to wait for him to go back to his usual routines and work. Hence, clamor of shortening the treatment regimen for patients with TB has been increasing to lessen the burden of those individuals and his support system.

Recently, the U.S. Center for Disease Control and Prevention (CDC) has released a new set of treatment guidelines which shortened the period of time for the treatment of individuals with latent tuberculosis. The new guidelines should be considerably shortened from about 9 months of treatment to about 3 months by simplifying the course of the treatment regimen.

The new set of guidelines which was published in the December issue of the CDC’s Morbidity and Mortality Weekly Report is to be carried out by the public health officials and health care providers which deemed to shorten the course of therapy. Although the treatment has been shortened, it does not necessarily mean that individuals will not reach the state of being TB free where the patient already is not harboring the microorganism. The new set of guidelines was based on the on clinical trials and opinions of experts.

Latent TB is not the same with full TB infection. Those individuals with latent TB mean that they are harboring the microorganisms inside their body and thus, considered as carrier of the disease. However, these individuals are considered not having full blown TB because they are still not manifesting any clinical signs and symptoms of the disease, but when their immune system has been weakened, the person might develop from a latent TB to an active TB.

Moreover, the new treatment regimen includes the treatment to 12 once-per-week doses of isoniazid, together with rifapentine. According to CDC Director Dr. Thomas Frieden, he said: “It is critical that we accelerate progress against TB in the United States in order to avoid a resurgence of the disease.”





Speak Your Mind


Current day month ye@r *